Clinical Trials Browser

Phase 1/2 × Standard of Care × 30 days × Clear all

NCT04565665 2026-03-10

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Phase 1/2 Recruiting

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT06502691 2026-03-02

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms

NCT07206056 2026-03-02

TulmiSTAR-01

Phase 1/2 Recruiting

Progressive Metastatic Castrate Resistant Prostate Cancer